was read the article
array:24 [ "pii" => "S217357431630065X" "issn" => "21735743" "doi" => "10.1016/j.reumae.2015.11.014" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "854" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2015" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2016;12:244-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1298 "formatos" => array:3 [ "EPUB" => 62 "HTML" => 812 "PDF" => 424 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1699258X1500203X" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2015.11.008" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "854" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2016;12:244-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7439 "formatos" => array:3 [ "EPUB" => 168 "HTML" => 5853 "PDF" => 1418 ] ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original</span>" "titulo" => "Características clínicas, tratamiento y complicaciones oculares de uveítis anterior asociada y no asociada a HLA-B27" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "244" "paginaFinal" => "247" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical characteristics, treatment and ocular complications of HLA-B27-related anterior uveitis and HLA-B27-non related anterior uveitis" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Elia Valls Pascual, Pablo Fontanilla Ortega, Elvira Vicens Bernabeu, Lucía Martínez-Costa, Ricardo Blanco Alonso" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Elia" "apellidos" => "Valls Pascual" ] 1 => array:2 [ "nombre" => "Pablo" "apellidos" => "Fontanilla Ortega" ] 2 => array:2 [ "nombre" => "Elvira" "apellidos" => "Vicens Bernabeu" ] 3 => array:2 [ "nombre" => "Lucía" "apellidos" => "Martínez-Costa" ] 4 => array:2 [ "nombre" => "Ricardo" "apellidos" => "Blanco Alonso" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S217357431630065X" "doi" => "10.1016/j.reumae.2015.11.014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357431630065X?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X1500203X?idApp=UINPBA00004M" "url" => "/1699258X/0000001200000005/v1_201608210048/S1699258X1500203X/v1_201608210048/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173574316300636" "issn" => "21735743" "doi" => "10.1016/j.reumae.2015.11.012" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "849" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2016;12:248-55" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1166 "formatos" => array:3 [ "EPUB" => 63 "HTML" => 812 "PDF" => 291 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Quality Standards for Rheumatology Outpatient Clinic. The EXTRELLA Project" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "248" "paginaFinal" => "255" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estándares de calidad asistencial para las consultas externas de reumatología. El proyecto EXTRELLA" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2617 "Ancho" => 1502 "Tamanyo" => 158408 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Dynamics of the generation of the final document.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Joan M. Nolla, Carmen Martínez, Rosario García-Vicuña, Daniel Seoane-Mato, M. Piedad Rosario Lozano, Alberto Alonso, Mercedes Alperi, Ceferino Barbazán, Jaime Calvo, Concepción Delgado, Antonio Fernández-Nebro, Lourdes Mateo, Trinidad Pérez Sandoval, José Pérez Venegas, Carlos Rodríguez Lozano, José Rosas" "autores" => array:17 [ 0 => array:2 [ "nombre" => "Joan M." "apellidos" => "Nolla" ] 1 => array:2 [ "nombre" => "Carmen" "apellidos" => "Martínez" ] 2 => array:2 [ "nombre" => "Rosario" "apellidos" => "García-Vicuña" ] 3 => array:2 [ "nombre" => "Daniel" "apellidos" => "Seoane-Mato" ] 4 => array:2 [ "nombre" => "M. Piedad" "apellidos" => "Rosario Lozano" ] 5 => array:2 [ "nombre" => "Alberto" "apellidos" => "Alonso" ] 6 => array:2 [ "nombre" => "Mercedes" "apellidos" => "Alperi" ] 7 => array:2 [ "nombre" => "Ceferino" "apellidos" => "Barbazán" ] 8 => array:2 [ "nombre" => "Jaime" "apellidos" => "Calvo" ] 9 => array:2 [ "nombre" => "Concepción" "apellidos" => "Delgado" ] 10 => array:2 [ "nombre" => "Antonio" "apellidos" => "Fernández-Nebro" ] 11 => array:2 [ "nombre" => "Lourdes" "apellidos" => "Mateo" ] 12 => array:2 [ "nombre" => "Trinidad" "apellidos" => "Pérez Sandoval" ] 13 => array:2 [ "nombre" => "José" "apellidos" => "Pérez Venegas" ] 14 => array:2 [ "nombre" => "Carlos" "apellidos" => "Rodríguez Lozano" ] 15 => array:2 [ "nombre" => "José" "apellidos" => "Rosas" ] 16 => array:1 [ "colaborador" => "Working Group of the EXTRELLA Project" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X15001904" "doi" => "10.1016/j.reuma.2015.11.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X15001904?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574316300636?idApp=UINPBA00004M" "url" => "/21735743/0000001200000005/v3_201704020032/S2173574316300636/v3_201704020032/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S217357431630079X" "issn" => "21735743" "doi" => "10.1016/j.reumae.2016.07.003" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "952" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Reumatol Clin. 2016;12:241-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2164 "formatos" => array:3 [ "EPUB" => 66 "HTML" => 1614 "PDF" => 484 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Vitamin D and cardiovascular disease in patients with systemic lupus erythematosus" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "241" "paginaFinal" => "243" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Vitamina D y enfermedades cardiovasculares en pacientes con lupus eritematoso sistémico" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mario García-Carrasco, Jose Luis Romero-Galvez" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Mario" "apellidos" => "García-Carrasco" ] 1 => array:2 [ "nombre" => "Jose Luis" "apellidos" => "Romero-Galvez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X16300870" "doi" => "10.1016/j.reuma.2016.07.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16300870?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357431630079X?idApp=UINPBA00004M" "url" => "/21735743/0000001200000005/v3_201704020032/S217357431630079X/v3_201704020032/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Clinical Characteristics, Treatment and Ocular Complications of HLA-B27-Related Anterior Uveitis and HLA-B27-Non Related Anterior Uveitis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "244" "paginaFinal" => "247" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Elia Valls Pascual, Pablo Fontanilla Ortega, Elvira Vicens Bernabeu, Lucía Martínez-Costa, Ricardo Blanco Alonso" "autores" => array:5 [ 0 => array:4 [ "nombre" => "Elia" "apellidos" => "Valls Pascual" "email" => array:1 [ 0 => "elialtea@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Pablo" "apellidos" => "Fontanilla Ortega" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Elvira" "apellidos" => "Vicens Bernabeu" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "Lucía" "apellidos" => "Martínez-Costa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 4 => array:3 [ "nombre" => "Ricardo" "apellidos" => "Blanco Alonso" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Sección de Reumatología, Hospital Universitari Doctor Peset, Valencia, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Oftalmología, Hospital Universitari Doctor Peset, Valencia, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Reumatología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Características clínicas, tratamiento y complicaciones oculares de uveítis anterior asociada y no asociada a HLA-B27" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Uveitis is inflammation of the middle layer of the eye (uvea), located between the sclera and the retina, which is comprised of the iris, ciliary body, pars plana and/or choroid. In some cases, by extension, it can also affect the retina.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The incidence of uveitis is 45–52 cases per 100,000<span class="elsevierStyleHsp" style=""></span>population/year, it peaks between the ages of 20 and 44 years, and the prevalence of the disease is 70 cases per 100<span class="elsevierStyleHsp" style=""></span>000 population.<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">1,2</span></a> It is the third leading cause of blindness in the working age population in developed countries, and 10% of the cases of total loss of vision are due to uveitis.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Anterior uveitis is the most common form of intraocular inflammation, representing between 50% and 92% of all cases of uveitis reported in a Western population.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">3</span></a> Anterior uveitis associated with HLA-B27 accounts for between 18% and 32% of the cases of anterior uveitis found in that population.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">4</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">It has been reported more frequently in men, in whom onset is earlier (20–40 years), it tends to be unilateral and there are higher rates of recurrences and complications. Anterior uveitis is more severe when associated with the HLA-B27 antigen, with a higher degree of inflammation and a more frequent use of systemic corticosteroids.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">5</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Objectives</span><p id="par0025" class="elsevierStylePara elsevierViewall">The purpose of this article is to describe the clinical features, the need for systemic therapy and the frequency and types of ocular complications in a cohort of patients with anterior uveitis associated with HLA-B27 and in a cohort of patients with endogenous noninfectious anterior uveitis not associated with HLA-B27.</p><p id="par0030" class="elsevierStylePara elsevierViewall">We also proposed to establish whether there were differences between the 2 cohorts in terms of clinical features, frequency and types of ocular complications, and the frequency of the use of systemic corticosteroids and other systemic immunosuppressive agents.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Material and Methods</span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Study Design and Patients</span><p id="par0035" class="elsevierStylePara elsevierViewall">We conducted a retrospective descriptive cohort study with analytical components, including patients diagnosed with anterior uveitis associated with HLA-B27 with follow-up in a multidisciplinary uveitis clinic at Hospital Universitari Doctor Peset in Valencia, Spain (HLA-B27+) and patients diagnosed with endogenous noninfectious anterior uveitis not associated with HLA-B27 with follow-up in the same multidisciplinary uveitis clinic at Hospital Universitari Doctor Peset (HLA-B27−).</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Inclusion Criteria</span><p id="par0040" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">–</span><p id="par0045" class="elsevierStylePara elsevierViewall">HLA B27+ cohort: patients diagnosed with anterior uveitis (acute, recurrent or chronic) associated with HLA-B27, with a follow-up of at least 1 month in the multidisciplinary uveitis clinic at Hospital Universitari Doctor Peset.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">–</span><p id="par0050" class="elsevierStylePara elsevierViewall">HLA B27− cohort: patients diagnosed with endogenous noninfectious anterior uveitis (acute, recurrent or chronic) not associated with HLA-B27, with a follow-up of at least 1 month in the multidisciplinary uveitis clinic at Hospital Universitari Doctor Peset.</p></li></ul></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Exclusion Criteria</span><p id="par0055" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">–</span><p id="par0060" class="elsevierStylePara elsevierViewall">Anterior uveitis associated with other locations (intermediate, posterior, panuveitis).</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">–</span><p id="par0065" class="elsevierStylePara elsevierViewall">Traumatic uveitis.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">–</span><p id="par0070" class="elsevierStylePara elsevierViewall">Infectious uveitis.</p></li></ul></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Data Collection and Variables</span><p id="par0075" class="elsevierStylePara elsevierViewall">The data were obtained from an electronic registry (.sav format) that includes patients who underwent follow-up between 1 January 2008 and 17 March 2015.</p><p id="par0080" class="elsevierStylePara elsevierViewall">The variables considered in the study were: length of follow-up, age, sex, diagnosis, clinical course according to the criteria of the Standardization of Uveitis Nomenclature (SUN) Working Group,<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">6</span></a> laterality, use of systemic immunosuppression, use of systemic corticosteroids, and presence and type of complications.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Data Management</span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Descriptive Statistics</span><p id="par0085" class="elsevierStylePara elsevierViewall">We calculated proportions for the categorical variables and mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation (or median and interquartile range if the data for the sample did not follow a normal distribution) for continuous variables.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Inferential Statistics</span><p id="par0090" class="elsevierStylePara elsevierViewall">The chi-square statistic was used to compare proportions, applying the continuity correction if necessary.</p><p id="par0095" class="elsevierStylePara elsevierViewall">Student's <span class="elsevierStyleItalic">t</span> statistic was utilized to compare means. If the data of the sample did not follow a normal distribution, the Kruskal–Wallis statistic was utilized.</p><p id="par0100" class="elsevierStylePara elsevierViewall">A <span class="elsevierStyleItalic">P</span> value <.05 was considered to indicate statistical significance.</p><p id="par0105" class="elsevierStylePara elsevierViewall">The statistical analysis was performed using the SPSS software package (version 13).</p></span></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Results</span><p id="par0110" class="elsevierStylePara elsevierViewall">We included a total of 162 patients, 58 with anterior uveitis associated with HLA-B27 (HLA-B27+) and 104 with endogenous noninfectious anterior uveitis not associated with HLA-B27 (HLA-B27−).</p><p id="par0115" class="elsevierStylePara elsevierViewall">Of the HLA-B27+ patients, 30 had a diagnosis of spondyloarthritis and 1 had a diagnosis of juvenile idiopathic arthritis (JIA). The different types of spondyloarthritis are shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>. We wish to point out the fact that 64.5% of these patients were diagnosed with spondyloarthritis after having been referred from the ophthalmology department to the rheumatology department after a first episode of uveitis. Most of these patients described symptoms characteristic of long-standing spondyloarthritis.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0120" class="elsevierStylePara elsevierViewall">Most of the HLA-B27− patients had been diagnosed with idiopathic uveitis. The various diagnoses included and their frequency in this cohort can be seen in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0125" class="elsevierStylePara elsevierViewall">The demographic and clinical characteristics of both cohorts are shown in <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>.</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0130" class="elsevierStylePara elsevierViewall">The mean age of the patients in the two cohorts was between 40 and 50 years, and there were no statistically significant differences between them.</p><p id="par0135" class="elsevierStylePara elsevierViewall">We did not observe a significant predominance of one sex over the other in either of the 2 cohorts, although there was a somewhat higher number of men in the HLA-B27+ cohort and of women in the HLA-B27− cohort.</p><p id="par0140" class="elsevierStylePara elsevierViewall">The median length of follow-up was greater in the HLA-B27+ cohort, but the difference did not reach statistical significance when compared with the HLA-B27− cohort.</p><p id="par0145" class="elsevierStylePara elsevierViewall">Likewise, no significant differences were found with regard to laterality; unilateral involvement was more frequent in both cohorts.</p><p id="par0150" class="elsevierStylePara elsevierViewall">However, differences were observed in terms of the clinical course. In the HLA-B27+ cohort, somewhat more than 2 thirds of the patients experienced recurrences and there were no cases of chronic uveitis. In the HLA-B27− cohort, half of the patients had had only 1 episode of uveitis, somewhat more than a fourth of the patients had a recurrent course, and the remainder, chronic.</p><p id="par0155" class="elsevierStylePara elsevierViewall">The proportion of patients who developed some type of complication was similar in both cohorts, there being no statistically significant differences (<span class="elsevierStyleItalic">P</span>=.686). However, when the types of complications that were documented for the patients in the 2 cohorts were analyzed, we observed differences, but the statistical significance could not be determined because the sample size was not large enough (<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>), except in the case of synechiae, which were more common in the HLA-B27+ cohort, although the difference was not statistically significant (<span class="elsevierStyleItalic">P</span>=.07). One patient in this cohort developed central serous choroiditis related to the use of systemic corticosteroids. In the HLA-B27− cohort, band keratopathy was observed in 6 patients, all of whom had been diagnosed with JIA. We also found a higher frequency of cataracts and ocular hypertension (OHT) in the HLA-B27− cohort. This fact was not associated with a more widespread use of systemic corticosteroids given that, as was seen in the case of cataracts, the higher frequency in the HLA-B27− cohort can be explained by a greater trend toward chronicity. In the case of OHT, the differences can be explained by the greater trend toward hypertension in some of the types of uveitis, such as Fuchs’ heterochromic iridocyclitis, included in the HLA-B27− cohort. The presence of OHT coincided with ocular inflammatory activity in all the patients.</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0160" class="elsevierStylePara elsevierViewall">Regarding the use of corticosteroids or other systemic immunosuppressive agents, again, there were no statistically significant differences, as these treatments were seldom required in either cohort (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>).</p><elsevierMultimedia ident="tbl0025"></elsevierMultimedia><p id="par0165" class="elsevierStylePara elsevierViewall">Most of the patients treated with systemic corticosteroids began the therapy with a dose of 30<span class="elsevierStyleHsp" style=""></span>mg a day of prednisone or the equivalent. In every case, immunosuppressive therapy was introduced due to ocular inflammatory activity that could not be controlled with other treatments, in general, to prevent recurrences or chronicity.</p><p id="par0170" class="elsevierStylePara elsevierViewall">The immunosuppressive agents utilized were sulfasalazine, methotrexate, adalimumab and tocilizumab (<a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a>).</p><elsevierMultimedia ident="tbl0030"></elsevierMultimedia></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Discussion</span><p id="par0175" class="elsevierStylePara elsevierViewall">There are a considerable number of publications dealing with the clinical features and prognosis of HLA-B27-associated anterior uveitis.<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">7–16</span></a></p><p id="par0180" class="elsevierStylePara elsevierViewall">The description of the clinical features coincides in the majority of the publications, but the prognosis does not. We found articles in which the authors reported a better prognosis for uveitis associated with HLA-B27,<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">7</span></a> whereas others affirmed the opposite,<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">8</span></a> and still others who observed a prognosis similar to that of anterior uveitis not associated with HLA-B27.<a class="elsevierStyleCrossRefs" href="#bib0125"><span class="elsevierStyleSup">9–13</span></a></p><p id="par0185" class="elsevierStylePara elsevierViewall">In contrast to earlier publications,<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">4,5</span></a> in the present study, we did not observe male predominance in the cohort of patients with anterior uveitis associated with HLA-B27, an earlier onset or a greater trend toward unilaterality in that cohort. However, we did find a greater trend toward recurrence in the patients with anterior uveitis associated with HLA-B27, similar to that reported in previous publications.<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">4,12</span></a> The rest of the clinical features were similar in both cohorts.</p><p id="par0190" class="elsevierStylePara elsevierViewall">One noteworthy finding is the high percentage of patients who were diagnosed with spondyloarthritis after being referred from the ophthalmology department to the rheumatology department due to an episode of uveitis. This circumstance demonstrates the importance of the collaboration between the two specialties.</p><p id="par0195" class="elsevierStylePara elsevierViewall">In this study, we did not take into account the degree of inflammatory activity at the time of the onset of the episode of uveitis because of the difficulty in standardizing the information, since the episodes were evaluated by different ophthalmologists and there was wide variability in terms of the establishment of the degree of inflammation.</p><p id="par0200" class="elsevierStylePara elsevierViewall">Likewise, we did not take into account the visual prognosis of the patients, as we considered that the study design was not the most appropriate for that assessment or for establishing prognostic factors. We would like to continue the study, carrying out a prospective evaluation of the patients for the purpose of clarifying this point.</p><p id="par0205" class="elsevierStylePara elsevierViewall">The fact that we found no statistically significant differences between the two cohorts in terms of the use of corticosteroids—in contrast to results published elsewhere<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">5</span></a>—and other systemic immunosuppressive agents, and the presence or absence of complications could indicate that the severity and the visual prognosis is comparable in the two groups, but we cannot reach any further conclusions because of the limitations of the study, which include the unavailability of data on the changes in the visual acuity of the patients. Moreover, in the HLA-B27− cohort, we observed an incidence of chronic uveitis of 21% and not a single case in the HLA-B27+ cohort. This difference would mean that, although the uveitides in the HLA-B27+ cohort were more severe, no significant differences were observed in terms of the use of systemic therapy on comparing the two cohorts, because in the patients with chronic uveitis, even if the activity was lower, systemic therapy would be initiated more often.</p><p id="par0210" class="elsevierStylePara elsevierViewall">With respect to the differences observed in the various types of ocular complications, which, as we mentioned above, cannot be measured accurately because of the small sample size, we should consider the influence of the heterogeneity in the HLA-B27− cohort, which includes 8 different diagnoses. This would explain, for example, the elevated presence of band keratopathy, observed only in those patients of the sample with a diagnosis of JIA.</p><p id="par0215" class="elsevierStylePara elsevierViewall">If we exclude synechiae, whose influence on the visual prognosis of the patient is low, the rate of complications is low in both cohorts.</p><p id="par0220" class="elsevierStylePara elsevierViewall">In conclusion, in the present article, there are no significant differences between the clinical features of uveitides associated with HLA-B27 and those of uveitides not associated with HLA-B27, with the exception of a greater trend toward recurrence.</p><p id="par0225" class="elsevierStylePara elsevierViewall">The study design does not enable us to establish differences with respect to the visual prognosis.</p><p id="par0230" class="elsevierStylePara elsevierViewall">We would like to increase the sample size of the study and carry out a prospective follow-up to obtain information on the differences in the development of different types of ocular complications, and on differences and possible factors that intervene in the prognosis.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Ethical Disclosures</span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Protection of human and animal subjects</span><p id="par0235" class="elsevierStylePara elsevierViewall">The authors declare that no experiments were performed on humans or animals for this study.</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Confidentiality of data</span><p id="par0240" class="elsevierStylePara elsevierViewall">The authors declare that they have followed the protocols of their work center on the publication of patient data.</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0150">Right to privacy and informed consent</span><p id="par0245" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article.</p></span></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0155">Conflict of Interest</span><p id="par0250" class="elsevierStylePara elsevierViewall">The authors declare they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:3 [ "identificador" => "xres823624" "titulo" => "Abstract" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objectives" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Material and methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Discussion" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec820290" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres823625" "titulo" => "Resumen" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivos" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Material y métodos" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec820291" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Objectives" ] 6 => array:3 [ "identificador" => "sec0015" "titulo" => "Material and Methods" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0020" "titulo" => "Study Design and Patients" ] 1 => array:2 [ "identificador" => "sec0025" "titulo" => "Inclusion Criteria" ] 2 => array:2 [ "identificador" => "sec0030" "titulo" => "Exclusion Criteria" ] 3 => array:2 [ "identificador" => "sec0035" "titulo" => "Data Collection and Variables" ] 4 => array:3 [ "identificador" => "sec0040" "titulo" => "Data Management" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0045" "titulo" => "Descriptive Statistics" ] 1 => array:2 [ "identificador" => "sec0050" "titulo" => "Inferential Statistics" ] ] ] ] ] 7 => array:2 [ "identificador" => "sec0055" "titulo" => "Results" ] 8 => array:2 [ "identificador" => "sec0060" "titulo" => "Discussion" ] 9 => array:3 [ "identificador" => "sec0065" "titulo" => "Ethical Disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0070" "titulo" => "Protection of human and animal subjects" ] 1 => array:2 [ "identificador" => "sec0075" "titulo" => "Confidentiality of data" ] 2 => array:2 [ "identificador" => "sec0080" "titulo" => "Right to privacy and informed consent" ] ] ] 10 => array:2 [ "identificador" => "sec0085" "titulo" => "Conflict of Interest" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-04-12" "fechaAceptado" => "2015-11-16" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec820290" "palabras" => array:3 [ 0 => "Anterior uveitis" 1 => "HLA-B27" 2 => "Ocular complications" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec820291" "palabras" => array:3 [ 0 => "Uveítis anterior" 1 => "HLA-B27" 2 => "Complicaciones oculares" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Anterior uveitis is the most common type of intraocular inflammation. Those associated to HLA-B27 represent 18 to 32% of all anterior uveitis cases.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objectives</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To describe clinical characteristics, systemic treatment need, and frequency and type of ocular complications in a cohort of patients diagnosed with HLAB27-related anterior uveitis and in a cohort of patients diagnosed with HLA-B27 non-related anterior uveitis.</p><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">To establish if statistically significant differences between both cohorts exist.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Material and methods</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">We performed a retrospective cohort study including patients with non infectious anterior uveitis related and not related to the antigen HLA-B27.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">162 patients were included, 58 diagnosed with HLA-B27-related anterior uveitis (cohort HLA-B27+1) and 104 diagnosed with HLA-B27-non related anterior uveitis (cohort HLA-B27−).</p><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">No statistically significant differences were found regarding clinical characteristics between both cohorts with the exception of a higher frequency of recurrences in cohort HLA-B27+ and a higher frequency of chronic uveitis in cohort HLA-B27−. No differences were found regarding systemic treatment use nor development of ocular complications.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Discussion</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">In contrast to previous studies, we neither found higher male gender predominance in the cohort of patients with HLA-B27-related anterior uveitis, nor did we find differences regarding average age, laterality, development of complications nor use of systemic corticosteroids.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objectives" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Material and methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Discussion" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Introducción</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">La uveítis anterior es la forma más frecuente de inflamación intraocular. Las formas asociadas al antígeno HLA-B27 suponen entre un 18 y un 32% de los casos de uveítis anterior.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivos</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Describir las características clínicas, la necesidad de tratamiento sistémico y la frecuencia y el tipo de complicaciones oculares de una cohorte de pacientes con uveítis anterior asociada a HLA-B27 y de una cohorte de pacientes con uveítis anterior no asociada a HLA-B27.</p><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Establecer si existen diferencias entre ambas cohortes.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Material y métodos</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Se realiza un estudio de cohortes retrospectivo descriptivo con componentes analíticos incluyendo a pacientes con uveítis anterior endógena no infecciosa asociada y no asociada a HLA-B27.</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Se incluye un total de 162 pacientes, 58 con uveítis anterior asociada a HLAB27 (cohorte HLA-B27+) y 104 con uveítis anterior no asociada a HLA-B27 (cohorte HLA-B27–).</p><p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">No se aprecian diferencias estadísticamente significativas en las características clínicas de ambas cohortes a excepción de una mayor tendencia a la recurrencia en la cohorte HLA-B27+ y una mayor tendencia a la cronicidad en la cohorte HLA-B27–. Tampoco se aprecian diferencias en cuanto al uso de tratamiento sistémico ni al desarrollo de complicaciones oculares de forma global.</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusiones</span><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">A diferencia de lo descrito con anterioridad, en este trabajo no encontramos un mayor predominio masculino en la cohorte de uveítis asociada a HLA-B27. Tampoco se aprecian diferencias en edad media, lateralidad, presencia de complicaciones ni frecuencia de uso de corticoides sistémicos.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivos" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Material y métodos" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Valls Pascual E, Fontanilla Ortega P, Vicens Bernabeu E, Martínez-Costa L, Blanco Alonso R. Características clínicas, tratamiento y complicaciones oculares de uveítis anterior asociada y no asociada a HLA-B27. Reumatol Clin. 2016;12:244–247.</p>" ] ] "multimedia" => array:6 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Type of spondyloarthritis \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">n (%) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ankylosing spondylitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19 (63.3) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Nonradiographic axial spondyloarthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6 (20) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Peripheral spondyloarthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (3.3) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Psoriatic spondyloarthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (3.3) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Spondyloarthritis associated with inflammatory bowel disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (3.3) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Undifferentiated spondyloarthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (6.6) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Total \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">30 (100) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1384871.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Association With Spondyloarthritis in the HLA-B27+ Cohort.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">TINU, tubulointerstitial nephritis and uveitis.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Diagnosis \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">n (%) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Idiopathic uveitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">81 (77.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Uveitis associated with juvenile idiopathic arthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 (6.7) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Uveitis associated with spondyloarthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6 (5.8) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">TINU syndrome \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 (2.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sjögren's syndrome \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (1.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Behçet's disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (1.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Fuchs’ heterochromic iridocyclitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (1.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Relapsing polychondritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (1) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Total \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">104 (100) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1384869.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Diagnoses in the HLA-B27− Cohort.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0095" class="elsevierStyleSimplePara elsevierViewall">A, acute; B, bilateral (simultaneous or alternating); C, chronic; M, men; M: women; R, recurrent; SD, standard deviation; U, unilateral.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Characteristics and features \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">HLA-B27+ (n=58) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">HLA-B27− (n=104) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age (years), mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">41<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>13.03 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">47.24<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>20.24 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.071 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " rowspan="2" align="left" valign="top">Sex, n (%)</td><td class="td" title="table-entry " align="left" valign="top">M 31 (53.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">M 42 (40.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.109 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">W 27 (46.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">W 62 (59.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Length of follow-up in months, median (interquartile range) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">34.5 (4.75–54) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13.5 (3–47) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.074 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " rowspan="2" align="left" valign="top">Laterality, n (%)</td><td class="td" title="table-entry " align="left" valign="top">U 36 (62.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">U 55 (52.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.259 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">B 22 (37.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">B 49 (47.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " rowspan="3" align="left" valign="top">Clinical course, n (%)</td><td class="td" title="table-entry " align="left" valign="top">A 19 (32.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">A 53 (51) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">R 39 (67.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">R 29 (27.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">C 0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">C 22 (21.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1384867.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">Patient Characteristics and Clinical Features.</p>" ] ] 3 => array:8 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at4" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0105" class="elsevierStyleSimplePara elsevierViewall">CSC, central serous choroiditis; ERM: epiretinal membrane; OHT, ocular hypertension.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Ocular complications \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">HLA-B27+ (n=58) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">HLA-B27− (n=104) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Synechiae \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19 (32.7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">23 (22.3%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Macular edema \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 (6.8%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9 (8.8%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cataracts \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (1.7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9 (8.8%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ERM \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (1.7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6 (5.9%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">OHT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6 (5.9%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Band keratopathy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 (4.8%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">CSC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (1.7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1384870.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0100" class="elsevierStyleSimplePara elsevierViewall">Ocular Complications.</p>" ] ] 4 => array:8 [ "identificador" => "tbl0025" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at5" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Systemic therapy \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">HLA-B27+ (n=58) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">HLA-B27− (n=104) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Corticosteroids \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8 (13.8%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">17 (16.3%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.666 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Other immunosuppressive agents \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11 (19%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19 (18.3%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.913 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1384866.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0110" class="elsevierStyleSimplePara elsevierViewall">Systemic Therapy.</p>" ] ] 5 => array:8 [ "identificador" => "tbl0030" "etiqueta" => "Table 6" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at6" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Systemic therapy \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">HLA-B27+ (n=11) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">HLA-B27− (n=19) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sulfasalazine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Methotrexate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Adalimumab \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Tocilizumab \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1384868.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0115" class="elsevierStyleSimplePara elsevierViewall">Types of Immunosuppressive Agents.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:16 [ 0 => array:3 [ "identificador" => "bib0085" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Causes and frequency of blindness in patients with intraocular inflammatory disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Rothova" 1 => "M.S. Suttorp-van Schulten" 2 => "W. Frits Tretters" 3 => "A. Kijlstra" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Ophthalmol" "fecha" => "1996" "volumen" => "80" "paginaInicial" => "332" "paginaFinal" => "336" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8703885" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0090" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and treatment of uveitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.C. Foster" 1 => "A.T. Vitale" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:4 [ "edicion" => "1st ed." "fecha" => "2002" "editorial" => "W.B. Saunders Company" "editorialLocalizacion" => "Philadelphia" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0095" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Uveitis: a global perspective" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.H. Chang" 1 => "D. Wakefield" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ocul Immunol Inflamm" "fecha" => "2002" "volumen" => "10" "paginaInicial" => "263" "paginaFinal" => "279" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12854035" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0100" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute anterior uveitis and HLA-B27" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.H. Chang" 1 => "P.J. McCluskey" 2 => "D. Wakefield" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.survophthal.2005.04.003" "Revista" => array:6 [ "tituloSerie" => "Surv Ophthalmol" "fecha" => "2005" "volumen" => "50" "paginaInicial" => "364" "paginaFinal" => "388" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15967191" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0105" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features and prognosis of HLA-B27 positive and negative anterior uveitis in a Korean population" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.C. Park" 1 => "D.I. Ham" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3346/jkms.2009.24.4.722" "Revista" => array:6 [ "tituloSerie" => "J Korean Med Sci" "fecha" => "2009" "volumen" => "24" "paginaInicial" => "722" "paginaFinal" => "728" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19654959" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0110" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Standarization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Standarization of uveitis nomenclature (SUN) Working Group" "etal" => false "autores" => array:3 [ 0 => "D.A. Jabs" 1 => "R.B. Nussenblatt" 2 => "J.T. Rosenbaum" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Ophthalmol" "fecha" => "2005" "volumen" => "140" "paginaInicial" => "509" "paginaFinal" => "516" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16196117" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0115" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features of HLA-B27 anterior uveitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Wakefield" 1 => "J. Easter" 2 => "R. Penny" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Experiment Ophthalmol" "fecha" => "1984" "volumen" => "12" "paginaInicial" => "191" "paginaFinal" => "196" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0120" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outcomes in anterior uveítis associated with the HLA-B27 haplotype" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "W.J. Power" 1 => "A. Rodríguez" 2 => "M. Pedroza-Seres" 3 => "C.S. Foster" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0161-6420(98)99033-9" "Revista" => array:7 [ "tituloSerie" => "Ophthalmology" "fecha" => "1998" "volumen" => "105" "paginaInicial" => "1646" "paginaFinal" => "1651" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9754172" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S147444220300588X" "estado" => "S300" "issn" => "14744422" ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0125" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "B27+ disease versus B27− disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A. Linssen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Scand J Rheumatol Suppl" "fecha" => "1990" "volumen" => "87" "paginaInicial" => "111" "paginaFinal" => "118" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2259879" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0130" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Linssen" 1 => "C. Meenken" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Ophthalmol" "fecha" => "1995" "volumen" => "120" "paginaInicial" => "351" "paginaFinal" => "361" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7661207" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0135" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features of acute anterior uveítis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Rothova" 1 => "W.G. van Veenedaal" 2 => "A. Linssen" 3 => "E. Glasius" 4 => "A. Kijlstra" 5 => "P.T. de Jong" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Ophthalmol" "fecha" => "1987" "volumen" => "103" "paginaInicial" => "137" "paginaFinal" => "145" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3492916" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0140" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "HLA-B27-associated acute anterior uveítis in a Turkish patient population" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Pathanapitoon" 1 => "S. Suksomboon" 2 => "P. Kunavisarut" 3 => "S. Ausayakhun" 4 => "S. Wattananikorn" 5 => "N. Leetrakool" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ocul Immunol Inflamm" "fecha" => "2005" "volumen" => "13" "paginaInicial" => "367" "paginaFinal" => "373" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16419422" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0145" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features and outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis in a Turkish patient population" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Tuncer" 1 => "Y.S. Adam" 2 => "M. Urgancioglu" 3 => "I. Tugal-Tutkun" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ocul Immunol Inflamm" "fecha" => "2005" "volumen" => "13" "paginaInicial" => "367" "paginaFinal" => "373" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16419422" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0150" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "D. Monnet" 1 => "M. Breban" 2 => "C. Hudry" 3 => "M. Dougados" 4 => "A.P. Brézin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ophtha.2003.07.011" "Revista" => array:6 [ "tituloSerie" => "Ophthalmology" "fecha" => "2004" "volumen" => "111" "paginaInicial" => "802" "paginaFinal" => "809" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15051216" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0155" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical manifestations of HLA-B27-positive acute anterior uveítis in Chinese" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Y.M. Chung" 1 => "T.S. Yeh" 2 => "J.H. Liu" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Zhonghua Yi Xue Za Zhi (Taipei)" "fecha" => "1989" "volumen" => "43" "paginaInicial" => "97" "paginaFinal" => "104" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0160" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M1 Huhtinen" 1 => "A. Karma" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Ophthalmol" "fecha" => "2000" "volumen" => "84" "paginaInicial" => "413" "paginaFinal" => "416" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10729301" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001200000005/v3_201704020032/S217357431630065X/v3_201704020032/en/main.assets" "Apartado" => array:4 [ "identificador" => "43294" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001200000005/v3_201704020032/S217357431630065X/v3_201704020032/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357431630065X?idApp=UINPBA00004M" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 11 | 12 | 23 |
2024 October | 57 | 26 | 83 |
2024 September | 76 | 19 | 95 |
2024 August | 76 | 34 | 110 |
2024 July | 63 | 59 | 122 |
2024 June | 66 | 36 | 102 |
2024 May | 74 | 27 | 101 |
2024 April | 57 | 17 | 74 |
2024 March | 45 | 27 | 72 |
2024 February | 29 | 27 | 56 |
2024 January | 40 | 23 | 63 |
2023 December | 46 | 38 | 84 |
2023 November | 46 | 23 | 69 |
2023 October | 49 | 27 | 76 |
2023 September | 78 | 31 | 109 |
2023 August | 37 | 17 | 54 |
2023 July | 51 | 28 | 79 |
2023 June | 33 | 25 | 58 |
2023 May | 57 | 28 | 85 |
2023 April | 26 | 19 | 45 |
2023 March | 65 | 22 | 87 |
2023 February | 61 | 28 | 89 |
2023 January | 40 | 18 | 58 |
2022 December | 57 | 25 | 82 |
2022 November | 51 | 27 | 78 |
2022 October | 47 | 40 | 87 |
2022 September | 38 | 40 | 78 |
2022 August | 45 | 43 | 88 |
2022 July | 38 | 39 | 77 |
2022 June | 31 | 38 | 69 |
2022 May | 39 | 37 | 76 |
2022 April | 49 | 38 | 87 |
2022 March | 68 | 56 | 124 |
2022 February | 57 | 33 | 90 |
2022 January | 54 | 60 | 114 |
2021 December | 52 | 51 | 103 |
2021 November | 44 | 48 | 92 |
2021 October | 68 | 68 | 136 |
2021 September | 43 | 34 | 77 |
2021 August | 41 | 37 | 78 |
2021 July | 54 | 46 | 100 |
2021 June | 62 | 43 | 105 |
2021 May | 82 | 53 | 135 |
2021 April | 214 | 116 | 330 |
2021 March | 97 | 49 | 146 |
2021 February | 66 | 22 | 88 |
2021 January | 74 | 30 | 104 |
2020 December | 59 | 29 | 88 |
2020 November | 51 | 15 | 66 |
2020 October | 41 | 13 | 54 |
2020 September | 60 | 28 | 88 |
2020 August | 46 | 24 | 70 |
2020 July | 67 | 21 | 88 |
2020 June | 55 | 21 | 76 |
2020 May | 57 | 15 | 72 |
2020 April | 38 | 22 | 60 |
2020 March | 21 | 11 | 32 |
2019 June | 1 | 0 | 1 |
2018 May | 3 | 1 | 4 |
2018 April | 38 | 11 | 49 |
2018 March | 67 | 15 | 82 |
2018 February | 45 | 8 | 53 |
2018 January | 24 | 14 | 38 |
2017 December | 24 | 10 | 34 |
2017 November | 40 | 6 | 46 |
2017 October | 14 | 14 | 28 |
2017 September | 29 | 14 | 43 |
2017 August | 29 | 19 | 48 |
2017 July | 30 | 13 | 43 |
2017 June | 38 | 26 | 64 |
2017 May | 43 | 28 | 71 |
2017 April | 49 | 30 | 79 |
2017 March | 32 | 24 | 56 |
2017 February | 17 | 22 | 39 |
2017 January | 20 | 17 | 37 |
2016 December | 41 | 36 | 77 |
2016 November | 39 | 36 | 75 |
2016 October | 82 | 42 | 124 |
2016 September | 72 | 27 | 99 |
2016 August | 34 | 11 | 45 |
2016 July | 1 | 0 | 1 |